Comments
Loading...
Biogen Stock Guidance | NASDAQ:BIIB | Benzinga
Biogen issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/01/2025 | BIIB | Biogen | FY | 2025 | $14.50 | $15.50 | $15.20 | — | — | — | Get Alert |
| 02/12/2025 | BIIB | Biogen | FY | 2025 | $15.25 | $16.25 | $16.24 | — | — | — | Get Alert |
| 10/30/2024 | BIIB | Biogen | FY | 2024 | $16.10 | $16.60 | $16.19 | — | — | — | Get Alert |
| 08/01/2024 | BIIB | Biogen | FY | 2024 | $15.75 | $16.25 | $15.58 | — | — | — | Get Alert |
| 04/24/2024 | BIIB | Biogen | FY | 2024 | $15.00 | $16.00 | $15.46 | — | — | — | Get Alert |
| 02/13/2024 | BIIB | Biogen | FY | 2024 | $15.00 | $16.00 | $15.65 | — | — | — | Get Alert |
| 11/08/2023 | BIIB | Biogen | FY | 2023 | $14.50 | $15.00 | $15.29 | — | — | — | Get Alert |
| 07/25/2023 | BIIB | Biogen | FY | 2023 | $15.00 | $16.00 | $15.42 | — | — | — | Get Alert |
| 04/25/2023 | BIIB | Biogen | FY | 2023 | $15.00 | $16.00 | $15.48 | — | — | — | Get Alert |
| 02/15/2023 | BIIB | Biogen | FY | 2023 | $15.00 | $16.00 | $15.72 | — | — | — | Get Alert |
| 10/25/2022 | BIIB | Biogen | FY | 2022 | $16.50 | $17.15 | $16.49 | $10.00B | $10.15B | $10.00B | Get Alert |
| 07/20/2022 | BIIB | Biogen | FY | 2022 | $15.25 | $16.75 | $15.54 | $9.90B | $10.10B | $9.84B | Get Alert |
| 05/03/2022 | BIIB | Biogen | FY | 2022 | $14.25 | $16.00 | $15.44 | $9.70B | $10.00B | $9.87B | Get Alert |
| 02/03/2022 | BIIB | Biogen | FY | 2022 | $14.25 | $16.00 | $18.85 | $9.70B | $10.00B | $10.34B | Get Alert |
| 10/20/2021 | BIIB | Biogen | FY | 2021 | $18.85 | $19.35 | $18.61 | $10.80B | $10.90B | $10.76B | Get Alert |
| 07/22/2021 | BIIB | Biogen | FY | 2021 | $17.50 | $19.00 | $18.59 | $10.65B | $10.85B | $10.63B | Get Alert |
| 04/22/2021 | BIIB | Biogen | FY | 2021 | $17.50 | $19.00 | $18.41 | $10.45B | $10.75B | $10.57B | Get Alert |
| 02/03/2021 | BIIB | Biogen | FY | 2021 | $17.00 | $18.50 | $24.67 | $10.45B | $10.75B | $11.22B | Get Alert |
| 10/21/2020 | BIIB | Biogen | FY | 2020 | $32.50 | $33.50 | $34.77 | $13.20B | $13.40B | $13.83B | Get Alert |
FAQ
What is the most recent guidance for Biogen (BIIB)?
The most recent guidance for Biogen (BIIB) was reported on May 1, 2025 for the full year 2025. The company provided earnings per share guidance in the range of $14.50 to $15.50, compared to the estimated EPS of $15.20. Additionally, Biogen forecasted revenue between $0.00B and $0.00B for the quarter.
Browse guidance and forecast on all stocks.
